How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    HTE10049 Intermittent urethral catheters _draft guidance_v1.1.docx

    Guidance development process

    NICE late-stage assessment (LSA) guidance evaluates categories of technologies that are already in widespread use within the NHS. It assesses whether price variations between technologies in a category are justified by differences in innovation, clinical effectiveness and patient benefits. This will support NHS commissioners, procurement teams, patients and healthcare professionals to choose technologies that maximise clinical effectiveness and value for money.

    Find out more on the NICE webpage on late-stage assessment (LSA) for medtech.

    NICE is producing this guidance on intermittent urethral catheters for long-term urinary management in the NHS in England. The medical technologies advisory committee has considered the evidence and the views of clinical and patient experts.

    This document has been prepared for consultation with the stakeholders. It summarises the evidence and views that have been considered and sets out the recommendations made by the committee. NICE invites comments from the stakeholders for this evaluation and the public. This document should be read along with the evidence.

    The committee is interested in receiving comments on the following:

    • Has all of the relevant evidence been taken into account?

    • Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?

    • Are the recommendations sound and a suitable basis for guidance to the NHS?

    • Are there any aspects of the recommendations that need particular consideration to ensure we avoid unlawful discrimination against any group of people on the grounds of age, disability, gender reassignment, pregnancy and maternity, race, religion or belief, sex or sexual orientation?

    After consultation:

    • Based on the consultation comments received, the committee may meet again.

    • If committee meets again it will consider the evidence, this evaluation consultation document and comments from stakeholders.

    • The committee will then prepare the final draft guidance, which will go through a resolution process before the final guidance is agreed.

    Note that this document is not NICE's final guidance on Intermittent urethral catheters for chronic incomplete bladder emptying in adults. The recommendations in section 1 may change after consultation.

    More details are available in NICE's health technology evaluations: the manual and NICE's late-stage assessment interim process and methods statement.

    Key dates:

    Closing date for comments: 7 March 2025

    Second committee meeting: 17 April 2025

    Comments panel open